We Don’t Want A New Drug
It’s an opioid, naturally. Synthetic in origin, probably highly addictive, if it doesn’t kill the user first — which it will probably do.
Read More
Author: C. Scott McMillin
The Money Behind The “Miracles”
…a young entrepreneur explained to me that medical use was never the ultimate goal of those who sought to commercialize psychedelic drugs. Therapy was fine, he claimed, but the real value lies in the potential for great wealth.
Read More
It’s Baaaack….Quaalude
…the virtual elimination of methaqualone from the streets is often touted as THE outstanding success story for law-enforcement in its efforts to stem the flow of drugs. A multi-agency campaign led by the DEA proved so effective that Quaalude seemed to simply disappear from the American drug scene.
Read More
A Patch for Prevention?
I can imagine some users — not all, but more than a few — will make use of the patch to facilitate further unaccompanied fentanyl use, confident now that they won’t inadvertently overdose. And being surprised when they did.
Read More
A Young Gambler’s story
It’s a common misconception, that somehow repeated failures precede eventual success. They don’t.
Read More